Shift Technologies, Inc. (SFT)
Oil News: China's Policy Shift and Middle East Turmoil Lift Crude Prices by 1%
Oil prices climb 1% as China signals growth-focused policy easing and Middle East unrest heightens geopolitical risks, impacting crude oil outlook.
Shift4: CEO Departure A Big Risk For Investors?
Shift4 has shown impressive growth, with revenue increasing from $766M to $2.5B since 2020, driven by strategic investments and acquisitions. Jared Isaacman's leadership and unique background in technology and aviation have been pivotal, but his potential departure for a NASA role poses a risk. Shift4 dominates the hospitality industry with cost-effective POS solutions, expanding market share and securing new contracts in hotels and international markets.
Trump nominates Jared Isaacman, private astronaut and Shift4 CEO, for NASA chief
President-elect Donald Trump on Wednesday nominated Jared Isaacman, a private astronaut and the billionaire CEO of Shift4, to be the next NASA Administrator. Isaacman has led two private spaceflights through SpaceX, including the company's first spacewalk in September.
Instil Bio's Strategic Shift To SYN-2510: A Speculative 'Buy' Opportunity
Instil Bio is a clinical-stage biotech focusing on personalized immunotherapy. SYN-2510 targets the promising PD-L1/VEGF oncology pathway. The company recently licensed assets from ImmuneOnco Biopharmaceuticals, retaining commercialization rights outside Greater China and enhancing its global market positioning. SYN-2510 is advancing to Phase 2 trials for NSCLC and TNBC, addressing a TAM forecasted to reach $43.7 billion by 2026.
Natural Gas and Oil Forecast: Will OPEC+ Policy Shift Impact Prices?
Explore how OPEC+ policy shifts and rising U.S. gasoline inventories impact energy prices and market sentiment.
Shift From Nvidia To This Stock As The Favorite, Traders Moving From Trump Trade To Bessent Trade
To gain an edge, this is what you need to know today.
Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
TORONTO, ON / ACCESSWIRE / November 20, 2024 / Biomind Labs Inc. (" Biomind " or the " Company ") (CBOE:BMND) (OTC PINK:BMNDF) (FRA:3XI) , a leading biotech company at the forefront of next-generation pharmaceuticals addressing the root causes of neurological disorders, is encouraged by the U.S. government's progressive stance on the psychedelic industry. The administration's decision to nominate a new Health Secretary with a history of supporting innovative mental health solutions marks a pivotal moment for the advancement of psychedelic-based therapies.
Qualcomm's Shift From Handsets To AI And Automotive Wins Analysts' Confidence
Several Wall Street analysts reiterated Qualcomm Inc QCOM after the company's 2024 investor day.
Shift4 CEO on earnings, state of the consumer and crypto
Jared Isaacman, Shift4 Payments founder & CEO, joins 'Closing Bell: Overtime' to discuss company earnings, fintech and consumer spending.
Shift4 Payments Set to Report Q3 Earnings: What's in the Offing?
FOUR's third-quarter 2024 revenues are likely to have gained from improvements across the hospitality, restaurant, and sports and entertainment verticals.
Grupo Aeorportuario Del Sureste: Tulum Pressure And Leisure Travel Shift Infuse Risk On This Buy
Despite a 12% stock decline and missed earnings, I maintain a buy rating for Grupo Aeroportuario del Sureste, though risks have increased. Cancun International Airport's traffic declined due to Tulum Airport's opening and a shift in American leisure travel to Europe. Third quarter revenues rose 18.1%, but EBITDA margins contracted due to higher costs in Puerto Rico, Mexico, and Colombia.
Semler Scientific: Topline Challenges Persist, While New Treasury Strategy Prompts A Shift
Semler has delivered 17% returns since we last wrote about it, but we are now looking to revise our stance. SMLR's Q3 earnings which came out yesterday was impressive on the headline front, but revenue attrition persists and will likely worsen in Q4. The onus now will shift to cash conversion, which SMLR continues to facilitate, but the pronounced degree of OPEX contractions looks to be fading.
